NCT06976073Recruiting
Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure
Source: ClinicalTrials.gov · Last updated 16 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical investigation is to explore a non-invasive technology for measuring the microcirculatory structure, composition and function in patients from a primary care population. The main aims are: 1. To evaluate the robustness of the technology for assessment of the molecular composition and structure of the skin tissue and microcirculatory function, on a prospective primary care population. 2. To evaluate the device and method on its capability to detect deficiencies in circulation, compared with existing reference systems with similar characteristics for patients with known cardiovascular disease risk and/or diabetes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 8000 (estimated)
- First submitted
- 28 Jul 2023
- Start date
- 1 Feb 2023
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- HJN Sverige AB/Neko Health
- Diseases
- Type 2 diabetes
- NCT number
- NCT06976073
What you commit to
- Study type: Observational
- Planned participants: 8000
- From 1 Feb 2023 to the primary completion date, 1 Jan 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive impairment
- Other severe disorder or terminal disease
Other
- Patients unable to understand the oral and written study information in Swedish or English
- Patients unable to provide an informed consent
- Patient´s with damaged, scarred or non-intact skin within the skin area of interest.
Who the study is looking for
- Adult patients part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation.
- Patients with signed informed consent
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Neko Health Centre, Sibyllegatan Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
| Atrium Health Care Centre Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
| Neko Health Centre, Regeringsgatan Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.